| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da142dbccc79b90b78d4a7e5def00a39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b21f650fc35b3e1947103e89adb06f3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5e95156255d5fe8b2923c544786e176
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_de27ae33fbe5d24a8fae0b047441cceb |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-20134
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-14143
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-542
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-20122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5252
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5256 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-16 |
| filingDate |
1994-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4bce15541b849d9b58c4e20f76dbe7d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e6a8ae3c6988166ad3c8343a182ee8c |
| publicationDate |
1995-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9509249-A1 |
| titleOfInvention |
Oral vaccination of mammals |
| abstract |
Oral anti-rabbies vaccines that comprise at least 100 νg of an isolated rabies glycoprotein G that is produced in eukaryotic cells and methods of immunizing mammals against rabies infection which comprise the step of orally administering to the mammal, such oral anti-rabies vaccine are disclosed. Chimeric proteins are disclosed. Orally active vaccines for immunizing a mammal against a pathogen infection comprising chimeric proteins and methods of using the same are disclosed. Oral anti-pathogen vaccines that comprise at least 100 νg of an isolated rabies glycoprotein G and either an isolated pathogen antigen or a peptide which comprises a neutralizing epitope of a pathogen antigen and methods of using the same are disclosed. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11497803-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8226952-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6673601-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8865461-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7727532-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7235245-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7238672-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8846051-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7901691-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7645455-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10695414-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7863041-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006084006-A1 |
| priorityDate |
1993-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |